Evidence map›Paper›PMID 28196762›Full record

ArticleThe Journal of allergy and clinical immunology2017

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota.

Amanda J McFarlane, Henry J McSorley, Donald J Davidson, Paul M Fitch, Claire Errington, Karen J Mackenzie, Eva S Gollwitzer, Chris J C Johnston, Andrew S MacDonald, Michael R Edwards and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Exposure tobioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Amanda J McFarlaneMRC-Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom; Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom.
Henry J McSorleyMRC-Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom; Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom.
Donald J DavidsonMRC-Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
Paul M FitchMRC-Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom; Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom.
Claire ErringtonNational Health Service Lothian, Simpson Centre for Reproductive Health, Edinburgh, United Kingdom.
Karen J MackenzieMRC-Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
Eva S GollwitzerFaculty of Biology and Medicine, University of Lausanne, Service de Pneumologie, CHUV, Lausanne, Switzerland.
Chris J C JohnstonInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Andrew S MacDonaldManchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, United Kingdom.
Michael R EdwardsAirway Disease Infection Section, MRC and Asthma UK Centre in Allergic Mechanisms of Asthma and Centre for Respiratory Infection, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Nicola L HarrisGlobal Health Institute, École Polytechnique, Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Benjamin J MarslandFaculty of Biology and Medicine, University of Lausanne, Service de Pneumologie, CHUV, Lausanne, Switzerland.
Rick M MaizelsInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Jürgen SchwarzeMRC-Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom; Child Life and Health, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: Jurgen.Schwarze@ed.ac.uk.
Centre for Inflammation Research · GBUniversity of Edinburgh · GBUniversity of Lausanne · CHAsthma UK · GBÉcole Polytechnique Fédérale de Lausanne · CHNational Health Service · GBUniversity of Manchester · GB

Funding

Medical Research Council G0701437Medical Research Council G0901697Medical Research Council G1000758Medical Research Council G1002046Medical Research Council MR/L008394/1
6 · The paper itself

Abstract

backgroundHelminth parasites have been reported to have beneficial immunomodulatory effects in patients with allergic and autoimmune conditions and detrimental consequences in patients with tuberculosis and some viral infections. Their role in coinfection with respiratory viruses is not clear.

objectiveHere we investigated the effects of strictly enteric helminth infection with Heligmosomoides polygyrus on respiratory syncytial virus (RSV) infection in a mouse model.

methodsA murine helminth/RSV coinfection model was developed. Mice were infected by means of oral gavage with 200 stage 3 H polygyrus larvae. Ten days later, mice were infected intranasally with either RSV or UV-inactivated RSV.

resultsH polygyrus-infected mice showed significantly less disease and pulmonary inflammation after RSV infection associated with reduced viral load. Adaptive immune responses, including T

conclusionThese data demonstrate that a strictly enteric helminth infection can have remote protective antiviral effects in the lung through induction of a microbiota-dependent type I interferon response.

Indexed as

AnimalsAntigens, HelminthCells, CulturedCoinfectionFemaleHumansImmunity, MucosalInterferon Type IIntestinesLungMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMicrobiotaNematospiroides dubiusAntigens, HelminthIfnar1 protein, mouseInterferon Type IReceptor, Interferon alpha-betaHeligmosomoides polygyrushelminthsmicrobiomeRespiratory syncytial virustype I interferon

Identifiers

PMID28196762
PMCPMC6485385
OpenAlexW2587192575

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.